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Abstract
Nitric oxide (NO) has several essential roles in mammals, but unregulated NO production can cause cell death through
oxidative stress, disrupted energy metabolism, DNA damage, activation of poly(ADP-ribose) polymerase, or dysregulation
of cytosolic calcium. Such disturbances can lead to either apoptotic or necrotic cell death, depending on the severity and
context of the damage. Here I review the mechanisms by which NO kills cells and discuss how NO thereby contributes to
ischaemia-reperfusion injury and neurodegeneration. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The controlled production of nitric oxide (NO) has
important roles in the human nervous, immune and
vascular systems [1^5]. Shortly after its discovery ex-
cessive or inappropriate production of NO was
found to cause cell death in human pathologies [6].
Whether NO is bene¢cial or harmful depends on the
type of cells exposed to and producing NO, the
chemical fate of NO, the amount of NO produced
and the site of its production. Here I overview how
NO damages and kills cells in human pathologies [5^
14].
2. Properties of NO relevant for cell death
2.1. Synthesis and di¡usion of NO
NO is produced by three di¡erent nitric oxide syn-
thases (NOS), two of which are constitutively ex-
pressed, predominantly in neurones (nNOS) and en-
dothelial tissue (eNOS), respectively [5,15,16]. The
major function of eNOS is to regulate vascular
tone, the main role for nNOS may be retrograde
signalling across synapses. An inducible form
(iNOS) can be upregulated considerably in immune
cells and many other tissues, where it is required for
the cellular immune response [17^20]. At normal in-
tracellular calcium levels NO production by iNOS is
limited only by the amount of enzyme, substrate or
cofactor present [6,17]. In contrast, eNOS and nNOS
are inactive at normal calcium concentrations, pro-
ducing ‘pu¡s’ of NO in response to transient in-
creases in cytosolic calcium, but chronic calcium el-
evation will cause persistent NO production [7].
Being small and hydrophobic, NO can pass easily
through membranes and as it persists in vivo for a
few seconds, it can di¡use several cell diameters from
its site of synthesis [11,21^23]. The transcellular dif-
fusion of NO is more rapid than the rate of its intra-
cellular reactions, consequently the steady-state NO
concentration experienced by a cell is determined by
the number of NO-producing cells nearby [21^23].
Hence NO is a paracrine messenger, rather than au-
tocrine, and NO-producing cells experience similar
NO concentrations to surrounding non-NO-produc-
ing cells [21]. As NO cannot be contained, it must be
removed by reaction after signalling, rather than by
reuptake [24].
2.2. Reactions of NO
In aqueous bu¡er NO decays to nitrite by a reac-
tion with O2 that is second order in NO and ¢rst
order in O2, consequently its decay rate is largely
determined by the NO concentration [24]. At maxi-
mum biological concentrations (1^5 WM) the half-life
of NO in vitro is several minutes, and it is far longer
at more usual physiological concentrations [23^26].
However, its biological half-life is only 1^10 s [25],
therefore in vivo NO decays by other pathways and
its uncatalysed reaction with oxygen is minimal [26].
As both NO and O2 are hydrophobic, they accumu-
late in lipid membranes, and most autoxidation to
nitrite in vivo occurs there [27]. NO reacts rapidly
with oxyhaemoglobin or oxymyoglobin to form ni-
trate [23,24,28]. The rapid rate of this reaction, to-
gether with the high haemoglobin concentration in
blood and the rapid di¡usion of NO, makes nitrate
the major endpoint of NO metabolism in vivo [23].
Furthermore, the steep NO concentration gradient
from tissues to blood lowers tissue NO concentra-
tions by decreasing the reentry of NO that has left
the cell [21].
NO and its products react with a large number of
biological molecules (see [7,29]), contributing to the
breadth of its signalling and deleterious e¡ects. Re-
action of NO with the haem of guanylyl cyclase leads
to cGMP production, thereby mediating many of the
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known physiological e¡ects of NO [20]. NO binds
directly to and inhibits several other haem enzymes
such as cytochrome oxidase, catalase and cyto-
chrome P-450 [24] and reacts with iron to form
iron-nitrosyl complexes in vivo [14]. Iron-sulphur
proteins are also particularly sensitive to NO dam-
age, probably due to formation of peroxynitrite
(ONOO3), a damaging derivative of NO [23,30].
The formation of S-nitrosothiols in£uences the ef-
fects of NO signalling and damage [29,31,32]. S-Ni-
trosothiols have longer half-lives in vivo than NO
and they are thought to increase the duration of
NO signalling by acting as NO reservoirs [29,32].
S-Nitrosothiols are widespread in vivo, but do not
arise from the direct reaction of NO with thiols
[23,26,33]. Instead, the oxidation of NO to a nitro-
sating species with considerable nitrosonium cation
(NO) character is required [29]. These can arise
from the reaction of NO with oxygen, superoxide
(Oc32 ) or transition metals [6]. Alternatively, S-nitro-
sothiols can be formed by the direct reaction of NO
with a thiyl radical [23]. The nitrosonium group can
be transferred from the S-nitrosothiol to other thiols
(transnitrosation), and NO can released from the
S-nitrosothiol by reduction [29,32,34,35].
The best understood S-nitrosylation of a protein
thiol is that of glyceraldehyde 3-phosphate dehydro-
genase (GAPDH), where S-nitrosylation both inacti-
vates the enzyme and leads to its ADP-ribosylation
by a non-enzymatic reaction [36]. Such S-nitrosyla-
tions and ADP-ribosylations of thiol proteins may be
widespread [29]. The formation of S-nitrosothiols,
and subsequent oxidation of thiol proteins, might
act as switches in signalling pathways [37,35] and
S-nitrosylation may regulate many thiol-containing
enzymes and regulatory proteins, such as the tran-
scription factors NF-UB, AP-1 and CREB [6,38^40],
G-proteins [41], ion channels and receptors [42] and
kinases [29,34,35,43].
2.3. NO and oxidative stress
Oxidative stress is the major cause of damage as-
sociated with elevated NO [6,23], resulting largely
from the formation of ONOO3 [23,44^48]. Reaction
of Oc32 with NO forms the short-lived ONOO
3 (half-
life 6 1 s) which is far more reactive and damaging
than its precursors [44]. This reaction is extremely
rapid, therefore ONOO3 forms whenever Oc32 and
NO are produced simultaneously. As Oc32 is formed
continually as a byproduct of oxidative metabolism
[49], a major role of superoxide dismutases (SODs)
may be to intercept Oc32 and prevent ONOO
3 for-
mation [23,44]. A consequence is that whenever the
NO concentration increases it will compete with
SOD for Oc32 , leading to ONOO
3 formation and
damage [23,47]. ONOO3 oxidatively damages a
wide range of biological molecules, including pro-
teins, lipids and nucleic acids, and also oxidises thi-
ols, nitrates protein tyrosine residues and damages
mitochondria [23,47,48]. Furthermore, ONOO3, as
its conjugate acid ONOOH (pKa 6.8), can di¡use
through membranes and cause damage some distance
from its site of synthesis [50].
NO also causes oxidative stress by other pathways.
NO reacts with oxygen to produce reactive oxides of
nitrogen (NOx), which may form preferentially with-
in lipid membranes [27], however the amount formed
in vivo is uncertain [26]. NO enhances the oxidative
stress caused by hydrogen peroxide [51]. The iron
liberated from ferritin by NO may contribute signi¢-
cantly to elevated oxidative stress [52]. NO reacts
rapidly with other radicals formed during oxidative
stress, such as lipid peroxides, but the signi¢cance of
these reactions in vivo is uncertain [53,54]. Interest-
ingly, NO can also protect against oxidative damage
by intercepting reactive species, such as the hydroxyl
radical, converting them to less damaging and more
easily detoxi¢ed products [26]. The relative rates of
production of NO and Oc32 are critical in determining
whether NO acts as a pro- or antioxidant [55].
2.4. Interaction of NO with mitochondria
NO interacts with mitochondria in a number of
ways that are central to its role in cell death [8,56].
Externally produced NO di¡uses easily into mito-
chondria and NO synthesis may also occur in mito-
chondria, catalysed by an organelle-speci¢c isoform
of NOS [57,58,157,158]. NO a¡ects mitochondria in
three principal ways: reversible inhibition of respira-
tion; irreversible inactivation of mitochondrial en-
zymes; and induction of the mitochondrial perme-
ability transition (PT). In addition, NO may
nitrosylate critical thiol residues on creatine kinase,
disrupting ATP supply by mitochondria [155,156].
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NO binds reversibly to haem a3 in cytochrome
oxidase and extremely low (nM) concentrations of
NO are su⁄cient to inhibit electron transport at
physiological oxygen levels [59]. Thus NO may rever-
sibly regulate mitochondrial function in vivo by
blocking respiration and ATP synthesis, and by caus-
ing the release of mitochondrial calcium [60^63]. Mi-
tochondria are a major source of Oc32 which forms
continually by electron leakage from the respiratory
chain [49,64]. NO di¡using into mitochondria reacts
with Oc32 to form ONOO
3 [65]. In addition, ONOO3
formed outside mitochondria can di¡use into the ma-
trix, although interception by cytoplasmic thiols
probably limits the damage so caused [66]. Interac-
tion of ONOO3 with the mitochondrial respiratory
chain causes further Oc32 formation [67] and ONOO
3
inactivates Mn-SOD, increasing Oc32 availability in
the mitochondrial matrix [68]. Hence NO may ini-
tiate a destructive cascade of ONOO3-mediated mi-
tochondrial damage events [56,68]. Respiratory chain
complexes I, II and III, and citric acid cycle enzymes
such as aconitase, contain iron-sulphur centres that
are irreversibly damaged by ONOO3 [30,66,69^72].
NO also inhibits glycolysis by S-nitrosylating and
thus inactivating GAPDH [36]. Therefore, NO con-
siderably impairs cellular ATP synthesis.
ONOO3 induces mitochondrial calcium e¥ux,
which can lead to the PT, by oxidising mitochondrial
thiols and NAD(P)H [73^76]. The PT is induced by
oxidative stress in conjunction with elevated calcium
which causes the formation of a 2^3 nm diameter
protein pore in the mitochondrial inner membrane,
depolarising and swelling the mitochondria, and re-
leasing solutes from the matrix [77,78]. NO might
also directly modulate induction of the PT [79] and
thereby contribute to both necrotic and apoptotic
cell death [77,80].
An important consequence of impaired energy me-
tabolism is the disruption of cellular calcium homeo-
stasis [78,81,82]. Depletion of ATP prevents cells
from maintaining transmembrane calcium gradients
by inhibiting endoplasmic reticulum and plasma
membrane Ca2-ATPases [78,81,82]. Mitochondria
also directly modulate cytosolic calcium and act as
a sink for excess cytosolic calcium [78,83]. The de-
crease in membrane potential and induction of the
PT will disrupt these processes, leading to elevated
cytoplasmic calcium [60,78].
2.5. DNA damage by NO and activation of PARP
and p53
Ribonucleotide reductase is inhibited by NO,
blocking the supply of deoxyribonucleotides for
DNA synthesis and slowing cell proliferation [84].
Excess NO also damages DNA, with ONOO3 caus-
ing single strand breaks [85,86]. Damaged DNA ac-
tivates poly(ADP-ribose) polymerase (PARP) in the
nucleus, probably to assist in DNA repair [87,88],
and upregulates p53 [7,13,89,90]. Activation of
PARP is particularly important in NO cytotoxicity
[91]. Activated PARP transfers up to 100 ADP-ri-
bose moieties from NAD to nuclear proteins in-
cluding histones and PARP itself [87,92] and the re-
sulting ADP-ribose polymers are then degraded by
glycohydrolases. The NAD resynthesis that follows
this futile cycle depletes ATP, while the decreased
availability of NAD severely compromises ATP
synthesis [92]. Hence a major consequence of DNA
damage by NO is a cellular energy de¢cit.
The tumour suppressor protein p53 [93] is also
upregulated in response to DNA damage caused by
NO [89,90], although depletion of ribonucleoside tri-
phosphate pools may also contribute [93]. DNA
damage increases the amount of p53 present by pro-
moting its phosphorylation, thus slowing its nor-
mally rapid proteolysis [93]. This upregulation of
p53 causes growth arrest by blocking the G1/S tran-
sition in the cell cycle giving time for DNA repair;
however, p53 will induce apoptosis if the DNA dam-
age is extreme [93]. In both cases p53 functions as a
transcription factor, increasing the expression of pro-
teins involved in DNA repair or apoptosis [93,94]. In
addition, p53 may interact directly with other pro-
teins, leading to apoptosis independently of its tran-
scriptional action [93].
2.6. Summary
Excessive NO production can arise from upregu-
lation of iNOS, or by exposing eNOS or nNOS to
chronically elevated calcium. The NO produced
easily di¡uses several cell diameters from its site of
synthesis. The local concentration of NO is a func-
tion of its rate of production and loss by both reac-
tion and di¡usion. Elevated NO can cause damage
by disrupting haem enzymes or forming S-nitroso-
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thiols, but most damage probably follows reaction
with Oc32 to form ONOO
3. The resulting oxidative
stress damages DNA, mitochondria and a range of
iron-containing enzymes; activates PARP and p53;
and disrupts energy metabolism and calcium homeo-
stasis (Fig. 1).
3. How does NO kill cells?
Cell death is generally considered to occur by two
distinct pathways: apoptosis, in which cells deliber-
ately activate an in-built death programme over sev-
eral hours, and necrosis (sometimes called oncosis)
which is the uncontrolled and rapid death of the cell
[95]. These two extremes are useful models for cell
death, but the mechanism of cell death in vivo prob-
ably involves a continuum from necrosis after ex-
treme cellular damage, to apoptosis following mild
damage or speci¢c extracellular signals [96].
3.1. Cell death following damage
As outlined above, excess NO causes oxidative
stress, DNA damage and disruption of energy me-
tabolism, calcium homeostasis and mitochondrial
function. All of these disturbances can lead to cell
death by apoptosis or necrosis, depending on the
context and severity of the damage [95,97,98].
Chronic elevation of cytosolic calcium activates a
wide range of cell damage pathways [81,99^102].
Small decreases in ATP levels lead to apoptosis,
while large decreases rapidly cause necrosis
[98,103]. Mild oxidative stress leads to apoptosis
whereas severe oxidative stress leads to extensive cel-
lular damage and necrotic cell death [96,99]. Mecha-
nisms for such extreme damage include activation of
PARP, depletion of cellular ATP levels, and the in-
duction of the mitochondrial PT [104]. These events
rapidly lead to necrosis by disrupting ion gradients,
swelling the cell and rupturing the plasma membrane
[95,105]. In contrast, if the damage is insu⁄cient to
cause necrosis, the upregulation of p53 stops cell
division and provides the opportunity for damaged
DNA to be repaired [93,97]. Beyond a certain dam-
age threshold the cell will undergo apoptosis, but
how it makes such a decision to die rather than to
undergo repair is uncertain (Fig. 2).
Cells can commit to apoptosis without inducing
new gene expression or protein synthesis, so the
apoptotic machinery is constitutively expressed with-
in the cytoplasm [106]. However, changes in tran-
scription can also initiate apoptosis [93]. Once apop-
tosis is initiated the cell gradually self-destructs,
dismantling itself and preparing the cell remnants
for removal by phagocytosis [97]. ATP is required
for this apoptotic pathway and if ATP becomes lim-
iting before its completion the mechanism will switch
to necrosis (in e¡ect, aborting apoptosis) [98,103].
Irreversible commitment to apoptosis involves cas-
pases, cytoplasmic cysteine proteases that are acti-
vated by proteolytic cleavage [107,108]. Caspases
are able to cleave a wide range of enzymes and pro-
teins, leading to the characteristic changes of apop-
tosis, including PARP inactivation, phosphatidylser-
ine exposure on the outer lea£et of the plasma
membrane, DNA fragmentation and the formation
of cellular remnants termed apoptotic bodies
[97,108,109]. Caspases can be inactivated by oxida-
tion or S-nitrosylation of a critical thiol residue
[118,119], perhaps partially explaining why excessive
oxidative stress generally leads to necrotic cell death,
not apoptosis.
How can NO-induced cell damage activate the cas-
Fig. 2. Dependence of cell response on severity of damage.
Fig. 1. Damaging reactions of NO. GCyc, guanylyl cyclase;
Hb, Haemoglobin; RS-NO, S-nitrosothiols ; RSH, thiols.
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pase cascade? One means of activating caspases is
the release of cytochrome c, and possibly other fac-
tors, from the mitochondrial intermembrane space
into the cytoplasm [106,110^112] (Fig. 3). This re-
lease is prevented by the anti-apoptotic proteins
Bcl-2 and Bcl-XL and activated by the pro-apoptotic
protein Bax [113]. Once in the cytoplasm, cyto-
chrome c binds to two proteins, Apaf 1 and procas-
pase 9, leading to the sequential activation of caspase
9 and caspase 3, thereby committing the cell to apop-
tosis [114]. The mechanism of cytochrome c release
is uncertain, but one possibility is that induction of
the mitochondrial PT swells the matrix and ruptures
the outer membrane to release cytochrome c [106,
115,116,137]. Therefore induction of the PT by
ONOO3 and elevated calcium is one possible mech-
anism by which NO activates apoptosis [56,137].
However, cytochrome c release often occurs without
apparent induction of the PT, therefore there may be
additional speci¢c mechanisms of cytochrome c re-
lease from mitochondria [110,111,113]. How this
might occur is uncertain, but pro-apoptotic proteins
such as Bax and Bak interact with the mitochondrial
outer membrane and thus may cause the release of
cytochrome c, which is opposed by the anti-apoptotic
proteins Bcl-2 and Bcl-XL. NO could activate this
pathway by altering the recruitment of these regula-
tory proteins to the mitochondrial outer membrane
[117], or by a¡ecting their relative amounts [93,113]
(Fig. 3).
Cytochrome c release and subsequent caspase ac-
tivation may enable cells to gauge whether the dam-
age sustained is su⁄cient to merit destruction by
apoptosis. Each cell contains several hundred mito-
chondria and release of cytochrome c from only a
few may favour release from others, because caspases
cleave anti-apoptotic proteins such as Bcl-XL, con-
verting them to pro-apoptotic proteins [120]. This
would favour further release of cytochrome c, and
would also inhibit the other anti-apoptotic activities
of Bcl-2 and Bcl-XL whereby they block caspase ac-
tivation by cytochrome c [120,121]. This potential
feedback loop may enable cells to integrate various
damage signals and undergo apoptosis when a crit-
ical proportion of their mitochondria have released
cytochrome c.
While caspase activation is not dependent on
changes in gene transcription or protein synthesis,
such changes in expression can contribute to apop-
totic cell death. Activation of p53 increases the ex-
pression of Bax [93,97], and other proteins that in-
crease oxidative stress and thus favour apoptosis
[94]. Other responses to NO-induced damage include
modulation of the activity of the transcription fac-
tors AP-1 [39], NF-UB [122] and CREB [123], and of
immediate early genes, but the mechanistic signi¢-
cance of these for apoptotic cell death remains un-
clear. Extracellular signals such as tumour necrosis
factor and FAS activate caspases by receptor-medi-
ated pathways which also commit the cell to apop-
tosis [97], so NO could contribute to apoptosis by
modulating these pathways.
3.2. Cell death in vitro in response to NO
Treatment of various cultured cells with excessive
NO leads to their death [7]. Since cells lacking
Cu,Zn-SOD are more susceptible to NO-induced
cell death, and ONOO3 causes cell death in a range
of cell types [124,125], NO appears to kill cells by
forming ONOO3 [126]. Large amounts of ONOO3
lead rapidly to necrotic cell death [96], whereas
smaller amounts promote apoptosis [96]. Since the
latter can be blocked by over-expressing Bcl-2
[126,127], apoptosis induced by NO or ONOO3
Fig. 3. Possible mechanisms of induction of apoptosis by nitric
oxide. PT, permeability transition; TNF/FAS, tumour necrosis
factor/FAS receptor pathways of caspase activation; c, cyto-
chrome c.
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probably follows release of cytochrome c and activa-
tion of caspases [137].
The activation of PARP by excessive NO also con-
tributes to cell death in vitro, particularly in neuro-
nes [91]. Glutamate in excess, or N-methyl-D-aspar-
tate (NMDA), causes neurotoxicity by activating the
NMDA receptor, increasing calcium uptake into the
cell and thus activating nNOS to produce excess NO
and ONOO3. The consequent damage to DNA [91]
leads to activation of PARP, depletion of ATP and
cell death that can be blocked by selective PARP
inhibitors [7,88,91,128]. In addition, cultured cerebral
cortical neurones from mice lacking the PARP gene
are resistant to the neurotoxic e¡ects of glutamate,
NMDA and NO [88,91]. Similarly, in a macrophage-
like cell line NO caused activation of PARP, accu-
mulation of p53 [7,127] and apoptosis, but in this
case PARP inhibitors did not prevent cell death
[90], suggesting that PARP activation was not central
to cell death. Mitochondrial ATP synthesis has a
critical role in deciding whether a cell dies by ne-
crosis or apoptosis [81,129], because ATP is required
for completion of the apoptotic programme. Neuro-
nes will undergo apoptosis if mitochondrial ATP
synthesis is retained during glutamate excitotoxicity,
but the cell will die by necrosis if mitochondrial ATP
synthesis is disrupted [81,129].
3.3. Summary
Elevated NO increases oxidative stress, damages
DNA and activates PARP, disrupting cellular energy
metabolism, mitochondrial function and calcium ho-
meostasis. All of these events occur simultaneously
to varying degrees and will be associated with
changes in gene expression and p53 activation. The
cell then has three options: to repair the damage, to
die by apoptosis, or to die by necrosis (Fig. 2). If the
damage is su⁄ciently extensive to deplete ATP or
inactivate caspases, apoptosis is impossible and the
cell will die by necrosis. If the damage is milder the
cell may repair itself during the growth arrest in-
duced by p53 activation, or deliberately induce apop-
tosis. In some situations the cell may initiate apop-
tosis, but then switch to necrosis following ATP
depletion or caspase inactivation.
4. NO and cell death in clinical situations
Over our lifetimes guanylyl cyclase is routinely ac-
tivated by low (nM) NO concentrations without
harmful consequences in a range of tissues [130].
The concentration of NO can be increased 10^100-
fold over normal levels (1^10 nM) causing both acute
and chronic damage [131]. For example, NO in-
creases up to 2^4 WM during cerebral ischaemia
[132] and can reach 4^5 WM above a layer of stimu-
lated endothelial cells in vitro [133]. Such increases in
NO concentration occur in both acute and chronic
situations in vivo and probably contribute to a range
of human diseases by the damage mechanisms out-
lined above. However, NO can also have protective
e¡ects, for example by increasing blood £ow and
inhibiting platelet aggregation [10], complicating the
interpretation of NO e¡ects in intact animals.
4.1. Acute NO injury
Both cerebral and peripheral neurones are partic-
ularly susceptible to cell death from acute NO over-
production during stroke and ischaemic brain injury,
with glutamate neurotoxicity being a major e¡ector
[8,91,134,135]. In ischaemia after a stroke the supply
of oxygen and glucose to the brain are blocked, lead-
ing to a decrease in plasma membrane potential and
release of glutamate from glutamatergic neurones.
The consequential stimulation of NMDA receptors
to take up calcium, promotes further glutamate re-
lease and a vicious cycle of NMDA receptor over-
stimulation (excitotoxicity) [8,134,135] and increased
NO production. During middle cerebral artery occlu-
sion in rats, cerebral NO rapidly increased to about
2^4 WM, returning to baseline levels after about 1 h
of ischaemia, and increasing again on reperfusion
[132]. Ischaemia will inevitably lead to cell death if
blood supply is not restored, however, reperfusion of
ischaemic tissue can also be damaging [136]. Likely
mechanisms of reperfusion injury include production
of Oc32 by oxygen-rich blood interacting with reduced
cell contents, activation of xanthine oxidase on en-
dothelial cells and numerous responses to disturbed
intracellular calcium homeostasis [136].
The use of selective nNOS inhibitors, or nNOS
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‘knock-out’ mice, led to substantially lower infarct
volumes during cerebral ischaemia, suggesting that
nNOS is responsible for producing the damaging
levels of NO [10,138]. How does activated nNOS
cause damage? It is not by stimulation of guanylyl
cyclase, as inhibitors do not a¡ect NMDA or NO
neurotoxicity [10]. Overexpression of Cu,Zn-SOD in
mice protects against cerebral ischaemic damage
[139] and mice lacking the Cu,Zn-SOD gene are
more susceptible to stroke damage [11,126]. Further-
more, NO alone is not neurotoxic in mouse models
of stroke [11]. Therefore, the reaction of Oc32 with
NO to form ONOO3 is required for neurotoxicity
[10]. It appears that DNA damage by ONOO3 lead-
ing to PARP activation is of particular importance
mechanistically [91]. Mice lacking the PARP gene
had 80% less tissue damage following middle cerebral
artery occlusion [91], and ADP-ribose polymer for-
mation was elevated in the ischaemic brain tissue of
normal mice [91]. PARP activation led to ATP de-
pletion and necrotic cell death, depending on the
severity of the damage [91,92].
Ischaemia-reperfusion injury in the brain leads to a
number of changes in gene expression and transcrip-
tion factor activity (for a review see [140]): these
include c-fos, c-jun, AP-1, NF-UB, CREB and p53.
Such changes will contribute to cell repair and apop-
tosis, depending on context [141]. A mixture of ne-
crosis and apoptosis is observed in animal models of
ischaemia-reperfusion injury, with the proportion de-
pending on the severity of the initial insult. Necrotic
cell death usually occurs at the centre of an ischaemic
lesion, with increased amounts of apoptosis towards
its periphery [140]. The dramatically reduced infarct
size in mice lacking the PARP gene suggests that
PARP activation and consequent ATP depletion
are major contributors to necrotic cell death in is-
chaemic lesions [91]. Apoptotic cell death in response
to relatively mild damage (either at the periphery of
the lesion or in response to a less severe insult) prob-
ably occurs by a combination of caspase activation
and transcriptional alterations, as discussed earlier,
but the details are uncertain.
The expression of iNOS in astrocytes and micro-
glial cells may also contribute to cell death following
ischaemia-reperfusion injury. While most neurones
express only nNOS, expression of iNOS can be in-
duced in glial cells and astrocytes by trauma or in-
fection [11,142] and increases in the brain a few
hours after ischaemia [8,10]. This upregulation of
iNOS may be required for phagocytosis of cells killed
during ischaemia. The NO produced by iNOS can
contribute to the cell death that occurs several hours
after the initial injury, and preliminary evidence sug-
gests that transgenic mice lacking iNOS have less
brain damage following ischaemia-reperfusion injury
[10].
4.2. Chronic NO damage
Mitochondrial damage and oxidative stress are ele-
vated in neurodegenerative disorders such as Parkin-
son’s disease and Alzheimer’s disease, and chronic
overproduction of NO has been suggested as a cause
of this damage [8,143]. Evidence supporting a role
for NO in the pathophysiology of neurodegenerative
diseases comes from the 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) model of Parkinson’s
disease. Inhibition of nNOS prevents MPTP toxicity
in baboons, and mice lacking nNOS are resistant to
MPTP toxicity [144,145]. Mice with elevated Cu,Zn-
SOD are also less susceptible to MPTP damage [146],
and 3-nitrotyrosine, a marker for ONOO3 forma-
tion, is found in the brains of mice exposed to
MPTP [147], suggesting that the reaction of NO
with Oc32 is the cause of the damage. This damage
may kill cells by a slow excitotoxic process, in which
mitochondrial dysfunction disrupts the maintenance
of transmembrane ion gradients, leading to chroni-
cally elevated calcium and activation of nNOS. The
ensuing oxidative stress and mitochondrial damage
would promote greater susceptibility to excitotoxic
cell death. The production of NO by iNOS may
also contribute to the mitochondrial dysfunction. Ex-
pression of iNOS increases in astrocytes and micro-
glial cells in response to cytokines and in£ammatory
stimuli [8,134] and the NO produced can di¡use to
neurones and disrupt their mitochondria [148^150].
As gliosis commonly occurs in neurodegenerative
diseases, this mechanism may contribute to the mi-
tochondrial dysfunction [151]. An interesting aspect
of neuronal cell death in both neurodegenerative dis-
eases and acute brain injury is that nNOS containing
neurones, which comprise about 2% of neurones in
the CNS, selectively survive cell death [4]. The reason
for this is uncertain, but one possibility is that nNOS
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expressing neurones have more e¡ective antioxidant
defenses than other neurones [8].
5. Conclusion
Excessive production of NO contributes to cell
death in ischaemia-reperfusion injury, neurodegener-
ative disorders and in£ammatory diseases. NO dam-
ages cells in a range of ways, but the most important
is by the production of ONOO3 which damages
DNA leading to PARP activation and ATP deple-
tion, and also directly disrupts mitochondrial func-
tion. These events can result in cell death by either
necrosis or apoptosis, or in the repair of the damage
and cell survival, depending on the severity and con-
text of the damage.
While NO-induced neuronal cell death is under-
stood in outline, more detailed temporal and spatial
knowledge of the molecular events in this and other
systems is required. In particular, a better under-
standing of why di¡erent cell types have altered sus-
ceptibilities to NO toxicity and die by a range of
mechanisms following exposure to NO would be in-
formative [7,66,152]. Recent work suggests that alter-
ations in cellular glutathione concentration may con-
tribute to these di¡erences [153]. It is also important
to determine how NO can protect against cell death,
and the role of cellular redox state in this process
[42,55]. In addressing these questions, the subtle
modulation of gene expression and signal transduc-
tion by NO is likely to prove central [123,154].
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